These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6390124)

  • 1. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 2. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin.
    Storms GE; Lutterman JA; van 't Laar A
    Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular size of insulin-anti-insulin immune complexes in the serum of diabetic patients].
    Brizzio AM; Nieto RR; Cedola N; Poskus E; Gagliardino JJ
    Medicina (B Aires); 1988; 48(2):113-9. PubMed ID: 3068475
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of type 1 diabetes with semisynthetic human insulin. 1 year's experience].
    Lunetta M; Rapisarda S; Leonardi R; Leotta S; Mughini L
    Minerva Endocrinol; 1984; 9(2):125-35. PubMed ID: 6390126
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of the hormonal and immune status of patients with newly detected diabetes mellitus].
    Dubrovskaia GV; Malyzhev VA; Sakalo EA
    Vrach Delo; 1989 Aug; (8):58-60. PubMed ID: 2588531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
    Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
    J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
    [No Abstract]   [Full Text] [Related]  

  • 13. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effects of the transition from animal insulin to biosynthetic human insulin].
    Gatti A; Dell'Aversano R; Monda M; Bonavita M; Bocchino C; Giacometti F; Carleo R
    Boll Soc Ital Biol Sper; 1987 Jul; 63(7):597-604, 610-1. PubMed ID: 3311081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
    Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A
    Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].
    Efimov AS; Malyzhev VA; Sakalo EA
    Ter Arkh; 1987; 59(11):15-8. PubMed ID: 3441859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Semisynthetic human insulin therapy of type 1 diabetics treated with a microinfusor. Preliminary notes on insulin requirements and antibody titer].
    Capani F; Consoli A; Vitacolonna E; Sensi S
    Minerva Endocrinol; 1984; 9(2):167-71. PubMed ID: 6503905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
    Di Mario U; Irvine WJ; Guy K; Borsey DQ; Iavicoli M; Ventriglia L
    J Clin Lab Immunol; 1983 May; 11(1):17-20. PubMed ID: 6348294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.